首页 > 最新文献

Medicc Review最新文献

英文 中文
Caution Ahead: Traffic Accidents in Cuba. 前方小心:古巴发生交通事故。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.6
Conner Gorry
{"title":"Caution Ahead: Traffic Accidents in Cuba.","authors":"Conner Gorry","doi":"10.37757/MR2022.V24.N1.6","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.6","url":null,"abstract":"","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"77"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39779057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccines and Public Trust: Containing COVID-19 in Cuba. 疫苗和公众信任:在古巴遏制COVID-19。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.11
Conner Gorry
<p><p>As 2021 drew to a close, Cuba struggled to contain the highly transmissible omicron variant of SARS-CoV-2, braced for a new wave of infections and kept a close eye on other variants of concern popping up around the world-a common experience to countries everywhere as we head into the second year of the pandemic. In Cuba, however, there is one marked difference making all the difference: by early January, 87% of the population was fully vaccinated using a three-dose schedule of vaccines developed and produced on the island.[1] This massive vaccination campaign is complemented by a rapid booster rollout-also using Cuban vaccines-that began in December 2021 and was ongoing as we finalized this issue. The island nation was able to achieve the third highest COVID-19 vaccination rate in the world[2] after decades of scientific investment, research, discovery and innovation; regulatory oversight and compliance; professional training; and increased production capacity. But a vaccine is only as effective as the health system charged with administering it-in a safe and timely manner, to as many people as possible. Here too, Cuba has decades of experience, including a national pediatric immunization program where 98% of children under 5 are immunized against 13 diseases,[3] an annual polio vaccination campaign (both launched in 1962 and uninterrupted since) and campaigns to contain epidemics such as H1N1. When the first COVID-19 cases were detected on the island in March 2020, Cuba harnessed this vaccine experience, making a hard tack towards developing its own vaccines. Two of the main protagonists in the country's biotechnology development, the Finlay Vaccine Institute (IFV) and the Genetic Engineering and Biotechnology Center (CIGB), both with several groundbreaking preventive and therapeutic vaccines in their portfolios, led the search for a vaccine. Today, Cuba has three vaccines authorized for emergency use-Soberana 02 and Soberana Plus developed by IFV, and Abdala, developed by CIGB. Schedules with these vaccines have demonstrated more than 90% efficacy in clinical trials,[4] and after regulatory approval for emergency use, became the backbone of Cuban COVID-19 vaccination efforts. A fourth vaccine, Mambisa (CIGB), administered nasally, and a fifth, Soberana 01 (IFV) are still in clinical trials. For this installment in MEDICC Review's series spotlighting leading women of Cuban science, we sat down with Dr Verena Muzio, Director of Clinical Research at CIGB. A pioneer of Cuba's biotechnology sector, she is an immunologist with a doctorate in biological sciences. Her professional trajectory began researching the genetically engineered hepatitis B surface antigen that led to the development of Cuba's recombinant hepatitis B vaccine in 1989. The same technological platform used in this vaccine was used to develop CIGB's Abdala vaccine against SARS-CoV-2-part of the reason Cuba was able to secure a vaccine so quickly. A phase 3 clinical trial deter
随着2021年接近尾声,古巴努力控制高度传染性的SARS-CoV-2的基因组变体,为新一波感染做好准备,并密切关注世界各地出现的其他令人担忧的变体——在我们进入大流行的第二年之际,这是世界各国的共同经历。然而,在古巴,有一个显著的差异造成了一切不同:到1月初,87%的人口完全接种了岛上开发和生产的三剂疫苗。[1]在这一大规模疫苗接种运动的补充下,还迅速推出了助推器——也是使用古巴疫苗——从2021年12月开始,在我们完成本期问题时一直在进行。经过数十年的科学投入、研究、发现和创新,这个岛国能够实现世界第三高的COVID-19疫苗接种率[2];监管监督和合规;专业培训;提高了生产能力。但是,疫苗的有效性取决于负责接种疫苗的卫生系统以安全和及时的方式为尽可能多的人接种疫苗。在这方面,古巴也有几十年的经验,包括一项全国儿科免疫规划,98%的5岁以下儿童接种了13种疾病的疫苗[3],每年开展脊髓灰质炎疫苗接种运动(1962年启动,此后一直没有中断),以及控制H1N1等流行病的运动。当2020年3月在岛上发现第一例COVID-19病例时,古巴利用这一疫苗经验,采取强硬措施开发自己的疫苗。该国生物技术发展的两个主要参与者——芬利疫苗研究所(IFV)和基因工程和生物技术中心(CIGB)——在其投资组合中都有几种突破性的预防性和治疗性疫苗,它们领导了疫苗的研究。今天,古巴有三种获准用于紧急用途的疫苗:国际疫苗研究所开发的Soberana 02和Soberana Plus,以及CIGB开发的Abdala。这些疫苗的接种计划在临床试验中显示出90%以上的有效性[4],并在监管部门批准紧急使用后,成为古巴COVID-19疫苗接种工作的支柱。第四种疫苗Mambisa (CIGB)是鼻用疫苗,第五种疫苗Soberana 01 (IFV)仍处于临床试验阶段。在《医学评论》聚焦古巴科学界女性领军人物系列的本期节目中,我们采访了CIGB临床研究主任Verena Muzio博士。她是古巴生物技术领域的先驱,拥有生物科学博士学位的免疫学家。她的职业轨迹始于研究基因工程乙型肝炎表面抗原,该抗原导致古巴在1989年开发出重组乙型肝炎疫苗。这种疫苗使用的相同技术平台被用于开发CIGB针对sars - cov的Abdala疫苗-古巴能够如此迅速地获得疫苗的部分原因。一项3期临床试验确定Abdala的有效率为92.28%,结果将发表在即将发表的出版物中。
{"title":"Vaccines and Public Trust: Containing COVID-19 in Cuba.","authors":"Conner Gorry","doi":"10.37757/MR2022.V24.N1.11","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.11","url":null,"abstract":"&lt;p&gt;&lt;p&gt;As 2021 drew to a close, Cuba struggled to contain the highly transmissible omicron variant of SARS-CoV-2, braced for a new wave of infections and kept a close eye on other variants of concern popping up around the world-a common experience to countries everywhere as we head into the second year of the pandemic. In Cuba, however, there is one marked difference making all the difference: by early January, 87% of the population was fully vaccinated using a three-dose schedule of vaccines developed and produced on the island.[1] This massive vaccination campaign is complemented by a rapid booster rollout-also using Cuban vaccines-that began in December 2021 and was ongoing as we finalized this issue. The island nation was able to achieve the third highest COVID-19 vaccination rate in the world[2] after decades of scientific investment, research, discovery and innovation; regulatory oversight and compliance; professional training; and increased production capacity. But a vaccine is only as effective as the health system charged with administering it-in a safe and timely manner, to as many people as possible. Here too, Cuba has decades of experience, including a national pediatric immunization program where 98% of children under 5 are immunized against 13 diseases,[3] an annual polio vaccination campaign (both launched in 1962 and uninterrupted since) and campaigns to contain epidemics such as H1N1. When the first COVID-19 cases were detected on the island in March 2020, Cuba harnessed this vaccine experience, making a hard tack towards developing its own vaccines. Two of the main protagonists in the country's biotechnology development, the Finlay Vaccine Institute (IFV) and the Genetic Engineering and Biotechnology Center (CIGB), both with several groundbreaking preventive and therapeutic vaccines in their portfolios, led the search for a vaccine. Today, Cuba has three vaccines authorized for emergency use-Soberana 02 and Soberana Plus developed by IFV, and Abdala, developed by CIGB. Schedules with these vaccines have demonstrated more than 90% efficacy in clinical trials,[4] and after regulatory approval for emergency use, became the backbone of Cuban COVID-19 vaccination efforts. A fourth vaccine, Mambisa (CIGB), administered nasally, and a fifth, Soberana 01 (IFV) are still in clinical trials. For this installment in MEDICC Review's series spotlighting leading women of Cuban science, we sat down with Dr Verena Muzio, Director of Clinical Research at CIGB. A pioneer of Cuba's biotechnology sector, she is an immunologist with a doctorate in biological sciences. Her professional trajectory began researching the genetically engineered hepatitis B surface antigen that led to the development of Cuba's recombinant hepatitis B vaccine in 1989. The same technological platform used in this vaccine was used to develop CIGB's Abdala vaccine against SARS-CoV-2-part of the reason Cuba was able to secure a vaccine so quickly. A phase 3 clinical trial deter","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"9-13"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39917723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effects of Physical Exercise on Burnout Syndrome in University Students. 体育锻炼对大学生倦怠综合征的影响
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.7
Yury Rosales-Ricardo, José P Ferreira

Introduction: Burnout syndrome has a negative impact on university students' health worldwide. Global prevalence of each dimension of the syndrome is estimated at 55.4% for emotional exhaustion, 31.6% for cynicism and 30.9% for academic inefficacy.

Objective: Evaluate the efficacy of physical exercise in reducing burnout levels in university students.

Methods: We carried out an investigation in students from the Technical University of Ambato, Ecuador. Students were in different career tracks, randomly selected, and were assigned to three different groups with pre-test and post-test measurements: two intervention groups (aerobic and strength exercise) and one control group (no exercise). The evaluation instrument was the Maslach Burnout Inventory-Student Survey, whose dimensions are exhaustion, cynicism and academic inefficacy. We also evaluated heart rate variability.

Results: The aerobic exercise group reduced cynicism by 21.1% (d = 0.252), inefficacy 13.1% (d = 0.397) and exhaustion by 31.0% (d = 0.532). The strength exercise group reduced cynicism by 27.4% (d = 0.315), inefficacy by 21.7% (d = 0.704) and exhaustion by 19.6% (d = 0.299). In the control group, exhaustion and inefficacy increased by 10.1% (d = 0.128) and 4.4% (d = 0.129) respectively; instead, cynicism was reduced by 7.3% (d = 0.062).The aerobic exercise group had the greatest increase in heart rate variability (at 16.8%), followed by the strength group (16.6%) and the control group (5.2%).

Conclusions: Physical exercise (both aerobic and strength) was effective in reducing burnout levels in university students.

职业倦怠综合症在世界范围内对大学生的健康产生了负面影响。据估计,该综合征各方面的全球患病率中,情绪衰竭占55.4%,玩世不恭占31.6%,学术无能占30.9%。目的:评价体育锻炼对降低大学生职业倦怠水平的作用。方法:对厄瓜多尔安巴托技术大学的学生进行调查。学生们在不同的职业道路上被随机选择,并按照测试前和测试后的测量分为三个不同的组:两个干预组(有氧运动和力量运动)和一个对照组(不运动)。评估工具为马斯拉奇倦怠量表-学生调查,量表维度为倦怠、玩世不恭和学业效能低下。我们还评估了心率变异性。结果:有氧运动组冷耻感降低21.1% (d = 0.252),无效感降低13.1% (d = 0.397),疲劳感降低31.0% (d = 0.532)。力量锻炼组愤世嫉俗减少27.4% (d = 0.315),效率低下减少21.7% (d = 0.704),疲惫减少19.6% (d = 0.299)。对照组疲劳程度和无效程度分别增加10.1% (d = 0.128)和4.4% (d = 0.129);相反,愤世嫉俗的人减少了7.3% (d = 0.062)。有氧运动组的心率变异性增加最多(16.8%),其次是力量组(16.6%)和对照组(5.2%)。结论:体育锻炼(有氧运动和力量运动)能有效降低大学生的倦怠水平。
{"title":"Effects of Physical Exercise on Burnout Syndrome in University Students.","authors":"Yury Rosales-Ricardo,&nbsp;José P Ferreira","doi":"10.37757/MR2022.V24.N1.7","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.7","url":null,"abstract":"<p><strong>Introduction: </strong>Burnout syndrome has a negative impact on university students' health worldwide. Global prevalence of each dimension of the syndrome is estimated at 55.4% for emotional exhaustion, 31.6% for cynicism and 30.9% for academic inefficacy.</p><p><strong>Objective: </strong>Evaluate the efficacy of physical exercise in reducing burnout levels in university students.</p><p><strong>Methods: </strong>We carried out an investigation in students from the Technical University of Ambato, Ecuador. Students were in different career tracks, randomly selected, and were assigned to three different groups with pre-test and post-test measurements: two intervention groups (aerobic and strength exercise) and one control group (no exercise). The evaluation instrument was the Maslach Burnout Inventory-Student Survey, whose dimensions are exhaustion, cynicism and academic inefficacy. We also evaluated heart rate variability.</p><p><strong>Results: </strong>The aerobic exercise group reduced cynicism by 21.1% (d = 0.252), inefficacy 13.1% (d = 0.397) and exhaustion by 31.0% (d = 0.532). The strength exercise group reduced cynicism by 27.4% (d = 0.315), inefficacy by 21.7% (d = 0.704) and exhaustion by 19.6% (d = 0.299). In the control group, exhaustion and inefficacy increased by 10.1% (d = 0.128) and 4.4% (d = 0.129) respectively; instead, cynicism was reduced by 7.3% (d = 0.062).The aerobic exercise group had the greatest increase in heart rate variability (at 16.8%), followed by the strength group (16.6%) and the control group (5.2%).</p><p><strong>Conclusions: </strong>Physical exercise (both aerobic and strength) was effective in reducing burnout levels in university students.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"36-39"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39779054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Cerebral Hemodynamic Reserve Abnormalities Detected Via Transcranial Doppler Ultrasound in Recovered COVID-19 Patients. 经颅多普勒超声检测COVID-19康复患者脑血流动力学储备异常
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.3
Anselmo Antonio Abdo-Cuza, Charles Hall-Smith, Juliette Suárez-López, Roberto Castellanos-Gutiérrez, Miguel Ángel Blanco-González, Rafael Machado-Martínez, Jonathan Pi-Ávila, Francisco Gómez-Peire, Namibia Espinosa-Nodarse, Juan C López-González

Introduction: SARS-CoV-2 infection can produce endothelial injury and microvascular damage, one cause of the multiorgan failure associated with COVID-19. Cerebrovascular endothelial damage increases the risk of stroke in COVID-19 patients, which makes prompt diagnosis important. Endothelial dysfunction can be evaluated by using transcranial Doppler ultrasound to study cerebral hemodynamic reserve, but there are few of these studies in patients with COVID-19, and the technique is not included in COVID-19 action and follow-up guidelines nationally or internationally.

Objective: Estimate baseline cerebral hemodynamic patterns, cerebral hemodynamic reserve, and breath-holding index in recovered COVID-19 patients.

Method: We conducted an exploratory study in 51 people; 27 men and 24 women 20-78 years of age, divided into two groups. One group comprised 25 recovered COVID-19 patients, following clinical and epidemiological discharge, who suffered differing degrees of disease severity, and who had no neurological symptoms or disease at the time they were incorporated into the study. The second group comprised 26 people who had not been diagnosed with COVID-19 and who tested negative by RT-PCR at the time of study enrollment. Recovered patients were further divided into two groups: those who had been asymptomatic or had mild disease, and those who had severe or critical disease. We performed transcranial Doppler ultrasounds to obtain baseline and post-apnea tests of cerebral hemodynamic patterns to evaluate cerebral hemodynamic reserve and breath-holding indices. We characterized the recovered patient group and the control group through simple descriptive statistics (means and standard deviations).

Results: There were no measurable differences in baseline cerebral hemodynamics between the groups. However, cerebral hemodynamic reserve and breath-holding index were lower in those who had COVID-19 than among control participants (19.9% vs. 36.8% and 0.7 vs. 1.2 respectively). These variables were similar for patients who had asymptomatic or mild disease (19.9% vs.19.8%) and for those who had severe or critical disease (0.7 vs. 0.7).

Conclusions: Patients recovered from SARS-CoV-2 infection showed decreased cerebral hemodynamic reserve and breath-holding index regardless of the disease's clinical severity or presence of neurological symptoms. These abnormalities may be associated with endothelial damage caused by COVID-19. It would be useful to include transcranial Doppler ultrasound in evaluation and follow-up protocols for patients with COVID-19.

SARS-CoV-2感染可导致内皮损伤和微血管损伤,这是导致COVID-19相关多器官衰竭的原因之一。脑血管内皮损伤增加了COVID-19患者中风的风险,因此及时诊断非常重要。经颅多普勒超声可评估内皮功能障碍,研究脑血流动力学储备,但对COVID-19患者的研究较少,且该技术未纳入国内或国际COVID-19行动及随访指南。目的:评估COVID-19康复患者的基线脑血流动力学模式、脑血流动力学储备和屏气指数。方法:我们对51人进行了探索性研究;27名男性和24名女性,年龄在20-78岁之间,分为两组。一组包括25名临床和流行病学出院后康复的COVID-19患者,他们患有不同程度的疾病严重程度,并且在纳入研究时没有神经系统症状或疾病。第二组包括26名未被诊断为COVID-19的人,他们在研究入组时通过RT-PCR检测呈阴性。康复患者进一步分为两组:无症状或轻度疾病患者和严重或危重疾病患者。我们通过经颅多普勒超声获得脑血流动力学模式的基线和呼吸暂停后测试,以评估脑血流动力学储备和呼吸保持指数。我们通过简单的描述性统计(均值和标准差)对康复患者组和对照组进行特征描述。结果:两组间基线脑血流动力学无显著差异。然而,COVID-19患者的脑血流动力学储备和屏气指数低于对照组(分别为19.9%对36.8%和0.7对1.2)。这些变量对于无症状或轻度疾病的患者(19.9% vs.19.8%)和患有严重或危重疾病的患者(0.7 vs. 0.7)相似。结论:无论临床严重程度或有无神经系统症状,SARS-CoV-2感染后康复的患者均表现为脑血流动力学储备和屏气指数下降。这些异常可能与COVID-19引起的内皮损伤有关。将经颅多普勒超声纳入COVID-19患者的评估和随访方案将是有益的。
{"title":"Cerebral Hemodynamic Reserve Abnormalities Detected Via Transcranial Doppler Ultrasound in Recovered COVID-19 Patients.","authors":"Anselmo Antonio Abdo-Cuza,&nbsp;Charles Hall-Smith,&nbsp;Juliette Suárez-López,&nbsp;Roberto Castellanos-Gutiérrez,&nbsp;Miguel Ángel Blanco-González,&nbsp;Rafael Machado-Martínez,&nbsp;Jonathan Pi-Ávila,&nbsp;Francisco Gómez-Peire,&nbsp;Namibia Espinosa-Nodarse,&nbsp;Juan C López-González","doi":"10.37757/MR2022.V24.N1.3","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.3","url":null,"abstract":"<p><strong>Introduction: </strong>SARS-CoV-2 infection can produce endothelial injury and microvascular damage, one cause of the multiorgan failure associated with COVID-19. Cerebrovascular endothelial damage increases the risk of stroke in COVID-19 patients, which makes prompt diagnosis important. Endothelial dysfunction can be evaluated by using transcranial Doppler ultrasound to study cerebral hemodynamic reserve, but there are few of these studies in patients with COVID-19, and the technique is not included in COVID-19 action and follow-up guidelines nationally or internationally.</p><p><strong>Objective: </strong>Estimate baseline cerebral hemodynamic patterns, cerebral hemodynamic reserve, and breath-holding index in recovered COVID-19 patients.</p><p><strong>Method: </strong>We conducted an exploratory study in 51 people; 27 men and 24 women 20-78 years of age, divided into two groups. One group comprised 25 recovered COVID-19 patients, following clinical and epidemiological discharge, who suffered differing degrees of disease severity, and who had no neurological symptoms or disease at the time they were incorporated into the study. The second group comprised 26 people who had not been diagnosed with COVID-19 and who tested negative by RT-PCR at the time of study enrollment. Recovered patients were further divided into two groups: those who had been asymptomatic or had mild disease, and those who had severe or critical disease. We performed transcranial Doppler ultrasounds to obtain baseline and post-apnea tests of cerebral hemodynamic patterns to evaluate cerebral hemodynamic reserve and breath-holding indices. We characterized the recovered patient group and the control group through simple descriptive statistics (means and standard deviations).</p><p><strong>Results: </strong>There were no measurable differences in baseline cerebral hemodynamics between the groups. However, cerebral hemodynamic reserve and breath-holding index were lower in those who had COVID-19 than among control participants (19.9% vs. 36.8% and 0.7 vs. 1.2 respectively). These variables were similar for patients who had asymptomatic or mild disease (19.9% vs.19.8%) and for those who had severe or critical disease (0.7 vs. 0.7).</p><p><strong>Conclusions: </strong>Patients recovered from SARS-CoV-2 infection showed decreased cerebral hemodynamic reserve and breath-holding index regardless of the disease's clinical severity or presence of neurological symptoms. These abnormalities may be associated with endothelial damage caused by COVID-19. It would be useful to include transcranial Doppler ultrasound in evaluation and follow-up protocols for patients with COVID-19.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"28-31"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39779052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Without Accessible Primary Care, We Are "Dangerously Unprepared" for the Next Pandemic. 没有可获得的初级保健,我们对下一次大流行“危险地毫无准备”。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.13
{"title":"Without Accessible Primary Care, We Are \"Dangerously Unprepared\" for the Next Pandemic.","authors":"","doi":"10.37757/MR2022.V24.N1.13","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.13","url":null,"abstract":"","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"4-5"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39917721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March-June 2020: Epidemiological Implications. 2020年3月至6月古巴哈瓦那无症状SARS-CoV-2感染:流行病学意义
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2022-01-31 DOI: 10.37757/MR2022.V24.N1.4
Elba Cruz-Rodríguez, Waldemar Baldoquín-Rodríguez, Niurka Molina-Águila, Belkys M Galindo-Santana, Manuel Romero-Placeres, Tania M González-Gross, Isabela Morgado-Vega, Yadira Olivera-Nodarse, María Guadalupe-Guzmán

Introduction: The percentage of asymptomatic COVID-19 cases worldwide is estimated at 18-50%; 53% in Cuba specifically, and 58% in Havana, the Cuban capital and the 2020 epicenter of the country's COVID-19 epidemic. These figures, however, do not represent the transmission capacity or behavior of asymptomatic cases. Understanding asymptomatic transmission's contribution to SARS-CoV-2 spread is of great importance to disease control and prevention.

Objective: Identify the epidemiological implications of asymptomatic SARS-CoV-2 infection in Havana, Cuba, during the first wave of the epidemic in 2020.

Methods: We carried out a cross-sectional study of all confirmed COVID-19 cases diagnosed in Havana, Cuba, from March 16 through June 30, 2020. The information was obtained through review of the standardized form for investigation of suspected and confirmed cases. Examined variables included age, sex, occupation, case type and source of infection. Cases were divided into asymptomatic and symptomatic groups, and transmission was characterized through the creation of a contact matrix. Analysis was carried out in Epidat and R.

Results: We studied 1287 confirmed cases, of which 57.7% (743) were asymptomatic, and 42.3% (544) were symptomatic. Symptomatic presentation was the most common for both imported and introduced cases, while asymptomatic presentation was more common in autochthonic cases and infections from an undetermined source. Asymptomatic infection was more common in groups aged ⟨20 and 20-59 years, while symptomatic infection was more common in those aged ⟩60 years. In the contact matrix, 34.6% of cases (445/1287) were not tied to other cases, and 65.4% (842/1287) were infectious-infected dyads, with symptomatic-symptomatic being the most common combination. The majority of primary cases (78.5%; 1002/1276) did not generate secondary cases, and 85.6% (658/743) of asymptomatic cases did not lead to other cases (although one asymptomatic superspreader led to 90 cases in a single event). However, 63.2% (344/544) of symptomatic primary cases generated secondary cases, and 11 symptomatic superspreaders spawned 100 secondary cases in different events.

Conclusions: Asymptomatic SARS-CoV-2 infection was the most common form of COVID-19 in Havana during the study period, but its capacity for contagion was lower than that of symptomatic individuals. Superspreader events under specific conditions played an important role in sustaining the epidemic.

导言:全球无症状COVID-19病例百分比估计为18-50%;具体来说,古巴占53%,古巴首都哈瓦那占58%,哈瓦那是2020年该国COVID-19流行病的中心。然而,这些数字并不代表无症状病例的传播能力或行为。了解无症状传播对新冠病毒传播的作用,对疾病防控具有重要意义。目的:探讨2020年第一波疫情期间古巴哈瓦那无症状SARS-CoV-2感染的流行病学意义。方法:我们对2020年3月16日至6月30日在古巴哈瓦那确诊的所有COVID-19确诊病例进行了横断面研究。这些信息是通过审查调查疑似病例和确诊病例的标准化表格获得的。检查的变量包括年龄、性别、职业、病例类型和感染源。病例被分为无症状组和有症状组,并通过建立接触者矩阵来确定传播特征。结果:共纳入确诊病例1287例,无症状者占57.7%(743例),有症状者占42.3%(544例)。在输入性和引入性病例中,症状表现最为常见,而在本土病例和来源不明的感染中,无症状表现更为常见。无症状感染以20岁和20-59岁年龄组多见,有症状感染以60岁年龄组多见。在接触者矩阵中,34.6%(445/1287)的病例没有与其他病例联系,65.4%(842/1287)的病例为感染双体,症状-症状组合是最常见的组合。多数原发病例(78.5%;1002/1276)未产生继发性病例,85.6%(658/743)的无症状病例未导致其他病例(尽管一名无症状超级传播者在一次事件中导致90例)。但在不同事件中,63.2%(344/544)有症状的原发病例产生了继发病例,11例有症状的超级传播者产生了100例继发病例。结论:无症状的SARS-CoV-2感染是研究期间哈瓦那最常见的COVID-19感染形式,但其传染能力低于有症状个体。特定条件下的超级传播者事件在维持流行病方面发挥了重要作用。
{"title":"Asymptomatic SARS-CoV-2 Infection in Havana, Cuba, March-June 2020: Epidemiological Implications.","authors":"Elba Cruz-Rodríguez,&nbsp;Waldemar Baldoquín-Rodríguez,&nbsp;Niurka Molina-Águila,&nbsp;Belkys M Galindo-Santana,&nbsp;Manuel Romero-Placeres,&nbsp;Tania M González-Gross,&nbsp;Isabela Morgado-Vega,&nbsp;Yadira Olivera-Nodarse,&nbsp;María Guadalupe-Guzmán","doi":"10.37757/MR2022.V24.N1.4","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.4","url":null,"abstract":"<p><strong>Introduction: </strong>The percentage of asymptomatic COVID-19 cases worldwide is estimated at 18-50%; 53% in Cuba specifically, and 58% in Havana, the Cuban capital and the 2020 epicenter of the country's COVID-19 epidemic. These figures, however, do not represent the transmission capacity or behavior of asymptomatic cases. Understanding asymptomatic transmission's contribution to SARS-CoV-2 spread is of great importance to disease control and prevention.</p><p><strong>Objective: </strong>Identify the epidemiological implications of asymptomatic SARS-CoV-2 infection in Havana, Cuba, during the first wave of the epidemic in 2020.</p><p><strong>Methods: </strong>We carried out a cross-sectional study of all confirmed COVID-19 cases diagnosed in Havana, Cuba, from March 16 through June 30, 2020. The information was obtained through review of the standardized form for investigation of suspected and confirmed cases. Examined variables included age, sex, occupation, case type and source of infection. Cases were divided into asymptomatic and symptomatic groups, and transmission was characterized through the creation of a contact matrix. Analysis was carried out in Epidat and R.</p><p><strong>Results: </strong>We studied 1287 confirmed cases, of which 57.7% (743) were asymptomatic, and 42.3% (544) were symptomatic. Symptomatic presentation was the most common for both imported and introduced cases, while asymptomatic presentation was more common in autochthonic cases and infections from an undetermined source. Asymptomatic infection was more common in groups aged &#10216;20 and 20-59 years, while symptomatic infection was more common in those aged &#10217;60 years. In the contact matrix, 34.6% of cases (445/1287) were not tied to other cases, and 65.4% (842/1287) were infectious-infected dyads, with symptomatic-symptomatic being the most common combination. The majority of primary cases (78.5%; 1002/1276) did not generate secondary cases, and 85.6% (658/743) of asymptomatic cases did not lead to other cases (although one asymptomatic superspreader led to 90 cases in a single event). However, 63.2% (344/544) of symptomatic primary cases generated secondary cases, and 11 symptomatic superspreaders spawned 100 secondary cases in different events.</p><p><strong>Conclusions: </strong>Asymptomatic SARS-CoV-2 infection was the most common form of COVID-19 in Havana during the study period, but its capacity for contagion was lower than that of symptomatic individuals. Superspreader events under specific conditions played an important role in sustaining the epidemic.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"21-27"},"PeriodicalIF":2.1,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39779051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. 糖尿病患者的伤口慢性化、免疫力下降和感染。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-09-17 eCollection Date: 2022-01-31 DOI: 10.37757/MR2021.V23.N3.8
Nadia Rodríguez-Rodríguez, Indira Martínez-Jiménez, Ariana García-Ojalvo, Yssel Mendoza-Mari, Gerardo Guillén-Nieto, David George Armstrong, Jorge Berlanga-Acosta
<p><strong>Background: </strong>Diabetic foot ulcers are a common diabetic complication leading to alarming figures of amputation, disability, and early mortality. The diabetic glucooxidative environment impairs the healing response, promoting the onset of a 'wound chronicity phenotype'. In 50% of ulcers, these non-healing wounds act as an open door for developing infections, a process facilitated by diabetic patients' dysimmunity. Infection can elicit biofilm formation that worsens wound prognosis. How this microorganism community is able to take advantage of underlying diabetic conditions and thrive both within the wound and the diabetic host is an expanding research field.</p><p><strong>Objectives: </strong>1) Offer an overview of the major cellular and molecular derangements of the diabetic healing process versus physiological cascades in a non-diabetic host. 2) Describe the main immunopathological aspects of diabetics' immune response and explore how these contribute to wound infection susceptibility. 3) Conceptualize infection and biofilim in diabetic foot ulcers and analyze their dynamic interactions with wound bed cells and matrices, and their systemic effects at the organism level. 4) Offer an integrative conceptual framework of wound-dysimmunity-infection-organism damage.</p><p><strong>Evidence aquisition: </strong>We retrieved 683 articles indexed in Medline/PubMed, SciELO, Bioline International and Google Scholar. 280 articles were selected for discussion under four major subheadings: 1) normal healing processes, 2) impaired healing processes in the diabetic population, 3) diabetic dysimmunity and 4) diabetic foot infection and its interaction with the host.</p><p><strong>Development: </strong>The diabetic healing response is heterogeneous, torpid and asynchronous, leading to wound chronicity. The accumulation of senescent cells and a protracted inflammatory profile with a pro-catabolic balance hinder the proliferative response and delay re-epithelialization. Diabetes reduces the immune system's abilities to orchestrate an appropriate antimicrobial response and offers ideal conditions for microbiota establishment and biofilm formation. Biofilm-microbial entrenchment hinders antimicrobial therapy effectiveness, amplifies the host's pre-existing immunodepression, arrests the wound's proliferative phase, increases localized catabolism, prolongs pathogenic inflammation and perpetuates wound chronicity. In such circumstances the infected wound may act as a proinflammatory and pro-oxidant organ superimposed onto the host, which eventually intensifies peripheral insulin resistance and disrupts homeostasis.</p><p><strong>Conclusions: </strong>The number of lower-limb amputations remains high worldwide despite continued research efforts on diabetic foot ulcers. Identifying and manipulating the molecular drivers underlying diabetic wound healing failure, and dysimmunity-driven susceptibility to infection will offer more effective therapeutic to
背景:糖尿病足溃疡是一种常见的糖尿病并发症,导致惊人的截肢、残疾和早期死亡数字。糖尿病的糖代谢环境损害了伤口的愈合反应,促进了 "伤口慢性化表型 "的出现。在 50%的溃疡中,这些无法愈合的伤口成为感染的温床,而糖尿病患者的免疫力低下又助长了这一过程。感染会导致生物膜的形成,使伤口预后恶化。这种微生物群落如何利用潜在的糖尿病条件,在伤口和糖尿病宿主体内繁衍生息,是一个不断扩展的研究领域:1) 概述糖尿病愈合过程与非糖尿病宿主生理级联的主要细胞和分子变化。2) 描述糖尿病患者免疫反应的主要免疫病理方面,并探讨这些方面如何导致伤口易感染。3) 构建糖尿病足溃疡中感染和生物膜的概念,分析它们与伤口床细胞和基质的动态相互作用,以及它们在机体层面的系统影响。4) 提供一个伤口-免疫力低下-感染-机体损伤的综合概念框架:我们检索了 Medline/PubMed、SciELO、Bioline International 和 Google Scholar 中收录的 683 篇文章。我们选择了 280 篇文章,按照四个主要小标题进行讨论:1)正常的愈合过程;2)糖尿病患者受损的愈合过程;3)糖尿病免疫功能障碍;4)糖尿病足感染及其与宿主的相互作用:发展:糖尿病的愈合反应是异质性的、迟缓的和不同步的,导致伤口慢性化。衰老细胞的积累和长期的炎症反应以及促代谢平衡阻碍了增殖反应,延迟了伤口的再上皮化。糖尿病降低了免疫系统协调适当的抗微生物反应的能力,为微生物群的建立和生物膜的形成提供了理想的条件。生物膜-微生物的固着阻碍了抗菌治疗的效果,加剧了宿主原有的免疫抑制,抑制了伤口的增殖期,增加了局部分解代谢,延长了致病性炎症的时间,并使伤口长期慢性化。在这种情况下,受感染的伤口可能成为叠加在宿主身上的促炎症和促氧化器官,最终加剧外周胰岛素抵抗,破坏体内平衡:尽管对糖尿病足溃疡的研究仍在继续,但全世界下肢截肢的人数仍然居高不下。识别和控制糖尿病伤口愈合失败以及免疫功能紊乱导致的易感染性的分子驱动因素,将为糖尿病患者提供更有效的治疗工具。
{"title":"Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.","authors":"Nadia Rodríguez-Rodríguez, Indira Martínez-Jiménez, Ariana García-Ojalvo, Yssel Mendoza-Mari, Gerardo Guillén-Nieto, David George Armstrong, Jorge Berlanga-Acosta","doi":"10.37757/MR2021.V23.N3.8","DOIUrl":"10.37757/MR2021.V23.N3.8","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Diabetic foot ulcers are a common diabetic complication leading to alarming figures of amputation, disability, and early mortality. The diabetic glucooxidative environment impairs the healing response, promoting the onset of a 'wound chronicity phenotype'. In 50% of ulcers, these non-healing wounds act as an open door for developing infections, a process facilitated by diabetic patients' dysimmunity. Infection can elicit biofilm formation that worsens wound prognosis. How this microorganism community is able to take advantage of underlying diabetic conditions and thrive both within the wound and the diabetic host is an expanding research field.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;1) Offer an overview of the major cellular and molecular derangements of the diabetic healing process versus physiological cascades in a non-diabetic host. 2) Describe the main immunopathological aspects of diabetics' immune response and explore how these contribute to wound infection susceptibility. 3) Conceptualize infection and biofilim in diabetic foot ulcers and analyze their dynamic interactions with wound bed cells and matrices, and their systemic effects at the organism level. 4) Offer an integrative conceptual framework of wound-dysimmunity-infection-organism damage.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Evidence aquisition: &lt;/strong&gt;We retrieved 683 articles indexed in Medline/PubMed, SciELO, Bioline International and Google Scholar. 280 articles were selected for discussion under four major subheadings: 1) normal healing processes, 2) impaired healing processes in the diabetic population, 3) diabetic dysimmunity and 4) diabetic foot infection and its interaction with the host.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Development: &lt;/strong&gt;The diabetic healing response is heterogeneous, torpid and asynchronous, leading to wound chronicity. The accumulation of senescent cells and a protracted inflammatory profile with a pro-catabolic balance hinder the proliferative response and delay re-epithelialization. Diabetes reduces the immune system's abilities to orchestrate an appropriate antimicrobial response and offers ideal conditions for microbiota establishment and biofilm formation. Biofilm-microbial entrenchment hinders antimicrobial therapy effectiveness, amplifies the host's pre-existing immunodepression, arrests the wound's proliferative phase, increases localized catabolism, prolongs pathogenic inflammation and perpetuates wound chronicity. In such circumstances the infected wound may act as a proinflammatory and pro-oxidant organ superimposed onto the host, which eventually intensifies peripheral insulin resistance and disrupts homeostasis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The number of lower-limb amputations remains high worldwide despite continued research efforts on diabetic foot ulcers. Identifying and manipulating the molecular drivers underlying diabetic wound healing failure, and dysimmunity-driven susceptibility to infection will offer more effective therapeutic to","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"44-58"},"PeriodicalIF":2.1,"publicationDate":"2021-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39523740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Haiti, Cubans Among First Responders, Again: Luis Orlando Oliveros-Serrano MD Coordinator, Cuban Medical Team in Haiti. 在海地,古巴人再次成为第一响应者:Luis Orlando Oliveros-Serrano医学博士,海地古巴医疗队协调员。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-08-21 eCollection Date: 2022-01-31 DOI: 10.37757/MR2022.V24.N1.1
Conner Gorry

Soaring summer temperatures, systematic urban and political violence, unreliable infrastructure-power outages, water shortages, sporadic transportation and interruption of other basic services-plus the illness, death and economic straits wrought by COVID-19, are what Haitians awake to every day. On the morning of August 14, 2021, they also woke to the earth in the throes of violent, lethal convulsions caused by a 7.2-magnitude earthquake, along the same fault line responsible for the devastating 2010 disaster and stronger still. As if this weren't enough, Tropical Storm Grace was bearing down on the nation, about to dump biblical amounts of rain on the heels of Tropical Storm Fred. When the Haitian President was assassinated on July 7, Haiti still had not received a single dose of any COVID-19 vaccine-indeed, it was the last country in the Americas to receive vaccines. Later that month, 500,000 doses arrived in the country, donated by the United States via COVAX, the WHO-led initiative to assure at least some vaccines reached low- and middle-income countries. In Haiti, getting those vaccines into the arms of the population is beset by cold chain, distribution and bureaucratic problems, and compounded by widespread vaccine hesitancy; when the earthquake struck, only 14,074 of those doses had been administered.[1,2] Suddenly there was a new, more urgent tragedy, the earthquake leaving thousands of dead, injured and displaced-perhaps hundreds of thousands once the real tally emerges. As in the 2010 quake, the doctors, nurses and technicians comprising Cuba's medical team in Haiti-a commitment Cuba has maintained with its Caribbean neighbor since 1998-were among the first responders. The 2010 relief effort included an additional 1500 health professionals and specialists from Cuba's Henry Reeve Emergency Medical Contingent. Just 24 hours after the August 14th quake, MEDICC Review spoke by phone with Dr Luis Orlando Oliveros-Serrano in Port-au-Prince, where he coordinates Cuba's medical team in Haiti. His disaster response experience had already taken him to Haiti twice before and to Pakistan, Bolivia and beyond.

夏季气温飙升、系统性的城市和政治暴力、不可靠的基础设施——停电、缺水、零星的交通和其他基本服务中断——加上COVID-19造成的疾病、死亡和经济困境,是海地人每天都要面对的问题。2021年8月14日上午,他们在一场7.2级地震引发的猛烈、致命的抽搐中醒来,地震发生在造成2010年毁灭性灾难的同一断层线上,而且强度更大。似乎这还不够,热带风暴格蕾丝正在向这个国家逼近,即将在热带风暴弗雷德之后倾倒圣经般的降雨。当海地总统于7月7日被暗杀时,海地仍然没有接种任何一剂COVID-19疫苗——事实上,它是美洲最后一个接种疫苗的国家。当月晚些时候,50万剂疫苗运抵该国,这是美国通过世卫组织主导的全球获取疫苗计划捐赠的,该计划旨在确保低收入和中等收入国家至少获得一些疫苗。在海地,让这些疫苗进入民众的怀抱受到冷链、分配和官僚问题的困扰,而且普遍存在的对疫苗的犹豫使情况更加复杂;当地震来袭时,只注射了14074剂。[1,2]突然间,一个新的、更紧迫的悲剧发生了,地震造成数千人死亡、受伤和流离失所——一旦真正的统计数字出来,可能会有数十万人。与2010年地震时一样,古巴在海地医疗队的医生、护士和技术人员是首批救援人员之一,古巴自1998年以来一直与这个加勒比海邻国保持着这种承诺。2010年的救济工作包括古巴亨利·里夫紧急医疗特遣队增派了1500名保健专业人员和专家。就在8月14日地震发生24小时后,《医学评论》通过电话采访了在太子港负责协调古巴海地医疗队的路易斯·奥兰多·奥利韦罗斯-塞拉诺医生。他的救灾经验已经把他带到了海地两次,巴基斯坦,玻利维亚和其他地方。
{"title":"In Haiti, Cubans Among First Responders, Again: Luis Orlando Oliveros-Serrano MD Coordinator, Cuban Medical Team in Haiti.","authors":"Conner Gorry","doi":"10.37757/MR2022.V24.N1.1","DOIUrl":"https://doi.org/10.37757/MR2022.V24.N1.1","url":null,"abstract":"<p><p>Soaring summer temperatures, systematic urban and political violence, unreliable infrastructure-power outages, water shortages, sporadic transportation and interruption of other basic services-plus the illness, death and economic straits wrought by COVID-19, are what Haitians awake to every day. On the morning of August 14, 2021, they also woke to the earth in the throes of violent, lethal convulsions caused by a 7.2-magnitude earthquake, along the same fault line responsible for the devastating 2010 disaster and stronger still. As if this weren't enough, Tropical Storm Grace was bearing down on the nation, about to dump biblical amounts of rain on the heels of Tropical Storm Fred. When the Haitian President was assassinated on July 7, Haiti still had not received a single dose of any COVID-19 vaccine-indeed, it was the last country in the Americas to receive vaccines. Later that month, 500,000 doses arrived in the country, donated by the United States via COVAX, the WHO-led initiative to assure at least some vaccines reached low- and middle-income countries. In Haiti, getting those vaccines into the arms of the population is beset by cold chain, distribution and bureaucratic problems, and compounded by widespread vaccine hesitancy; when the earthquake struck, only 14,074 of those doses had been administered.[1,2] Suddenly there was a new, more urgent tragedy, the earthquake leaving thousands of dead, injured and displaced-perhaps hundreds of thousands once the real tally emerges. As in the 2010 quake, the doctors, nurses and technicians comprising Cuba's medical team in Haiti-a commitment Cuba has maintained with its Caribbean neighbor since 1998-were among the first responders. The 2010 relief effort included an additional 1500 health professionals and specialists from Cuba's Henry Reeve Emergency Medical Contingent. Just 24 hours after the August 14th quake, MEDICC Review spoke by phone with Dr Luis Orlando Oliveros-Serrano in Port-au-Prince, where he coordinates Cuba's medical team in Haiti. His disaster response experience had already taken him to Haiti twice before and to Pakistan, Bolivia and beyond.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"24 1","pages":"19-20"},"PeriodicalIF":2.1,"publicationDate":"2021-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39520816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Improved Recovery Protocols in Cardiac Surgery: A Systematic Review and Meta-Analysis of Observational and Quasi-Experimental Studies. 心脏手术中改进的恢复方案:观察性和准实验研究的系统回顾和荟萃分析。
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-07-01 DOI: 10.37757/MR2021.V23.N3.9
María O Agüero-Martínez, Víctor M Tapia-Figueroa, Tania Hidalgo-Costa
<p><strong>Introduction: </strong>Improved recovery protocols were implemented in surgical specialties over the last decade, which decreased anesthetic and surgical stress and the incidence of perioperative complications. However, these recovery protocols were introduced more slowly for cardiac surgeries. The most frequent complications in cardiac surgery are related to patient clinical status and the characteristics of the surgical procedures involved, which are becoming more varied and complex every day. The first version of the enhanced recovery program for cardiac surgery was published in 2019, but its recommendations were based on only a few studies, and scant research has evaluated its implementation. Randomized and controlled clinical trials for these protocols are scarce, so research that summarizes the results of studies with other methodological designs are useful in demonstrating their benefits in cardiovascular surgery services in Cuba and in other limited-resource settings.</p><p><strong>Objective: </strong>Estimate the effectiveness of improved recovery protocols in the perioperative evolution of patients undergoing cardiac surgery.</p><p><strong>Methods: </strong>We performed a systematic review and meta-analysis according to the guidelines of manual 5.1.0 for reviews of the Cochrane library. We included observational and quasi-experimental studies published from January 2015 through May 2020 that compared enhanced recovery protocols with conventional treatments in patients older than 18 years, and used a quality score to evaluate them. We used the following sources: the Cochrane Library, PubMed, LILACS, SciELO, EBSCO, Google Scholar, Web of Science, Clinical Key, ResearchGate and HINARI. The following keywords were used for the database searches in English: ERAS, protocols and cardiac surgery, enhanced recovery after cardiac surgery, ERACS, clinical pathway recovery and cardiac surgery, perioperative care and cardiac surgery. We used the following search terms for databases in Spanish: protocolos de recuperación precoz and cirugía cardiaca, protocolos de recuperación mejorada and cirugía cardiaca, cuidados perioperatorios and cirugía cardiaca, programas de recuperación precoz and cirugía cardiovascular. Methodological quality of included investigations was evaluated using the surgical research methodology scale. Meta-analyses were performed for perioperative complications, intensive care unit and hospital stays, and hospital readmission within 30 days of surgery. We calculated effect sizes of the interventions and the corresponding 95% confidence intervals. We used mean differences and confidence intervals for continuous variables, and for qualitative variables we calculated relative risk (RR). Random effects analysis was used. Heterogeneity of the studies was assessed using the Q statistic and the I2 statistic.</p><p><strong>Results: </strong>We selected 15 studies (a total of 5059 patients: study group, n = 1706; control group,
在过去的十年中,外科专业实施了改进的恢复方案,减少了麻醉和手术压力以及围手术期并发症的发生率。然而,这些恢复方案在心脏手术中引入的速度较慢。心脏外科手术中最常见的并发症与患者的临床状况和所涉及的外科手术的特点有关,这些并发症日益多样化和复杂化。心脏手术增强康复计划的第一版于2019年发布,但其建议仅基于少数研究,很少有研究对其实施情况进行评估。这些方案的随机对照临床试验很少,因此总结其他方法学设计的研究结果的研究有助于证明其在古巴心血管外科服务和其他资源有限的环境中的益处。目的:评估改进的康复方案在心脏手术患者围手术期发展中的有效性。方法:我们根据Cochrane图书馆文献手册5.1.0的指南进行系统综述和荟萃分析。我们纳入了2015年1月至2020年5月期间发表的观察性和准实验性研究,这些研究比较了18岁以上患者的增强恢复方案与常规治疗方案,并使用质量评分对其进行评估。我们使用了以下来源:Cochrane Library, PubMed, LILACS, SciELO, EBSCO, Google Scholar, Web of Science, Clinical Key, ResearchGate和HINARI。数据库检索使用英文关键词:ERAS、方案和心脏手术、心脏手术后增强恢复、ERACS、临床路径恢复和心脏手术、围手术期护理和心脏手术。我们在西班牙语数据库中使用以下搜索词:protocolos de recuperación precoz和cirugía cardiaca, protocolos de recuperación mejorada和cirugía cardiaca, guidados perioperorios和cirugía cardiaca, programas de recuperación precoz和cirugía cardiovascular。采用外科研究方法学量表评估纳入调查的方法学质量。对围手术期并发症、重症监护病房和住院时间以及手术30天内再次住院进行meta分析。我们计算了干预措施的效应量和相应的95%置信区间。对于连续变量,我们使用均值差异和置信区间,对于定性变量,我们计算相对风险(RR)。采用随机效应分析。采用Q统计量和I2统计量评估研究的异质性。结果:我们选择了15项研究(共5059例患者:研究组,n = 1706;对照组,n = 3353)。纳入的15篇文章的平均质量得分为18.9分(根据量表最高36分),66.6%的文章得分为18分。随着心脏手术恢复方案的改进,围手术期并发症的发生率降低(RR = 0.73;95% CI 0.52-0.98),术后30天内再入院(RR = 0.51;95% ci 95% ci: 0.31-0.86)。拔管时间、住院时间和重症监护病房住院时间的差异不太明显,但总是有利于实施强化方案的组。结论:改进的心脏手术恢复方案提高了护理质量,围手术期并发症的减少和术后一个月内再入院的发生率降低。
{"title":"Improved Recovery Protocols in Cardiac Surgery: A Systematic Review and Meta-Analysis of Observational and Quasi-Experimental Studies.","authors":"María O Agüero-Martínez,&nbsp;Víctor M Tapia-Figueroa,&nbsp;Tania Hidalgo-Costa","doi":"10.37757/MR2021.V23.N3.9","DOIUrl":"https://doi.org/10.37757/MR2021.V23.N3.9","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Improved recovery protocols were implemented in surgical specialties over the last decade, which decreased anesthetic and surgical stress and the incidence of perioperative complications. However, these recovery protocols were introduced more slowly for cardiac surgeries. The most frequent complications in cardiac surgery are related to patient clinical status and the characteristics of the surgical procedures involved, which are becoming more varied and complex every day. The first version of the enhanced recovery program for cardiac surgery was published in 2019, but its recommendations were based on only a few studies, and scant research has evaluated its implementation. Randomized and controlled clinical trials for these protocols are scarce, so research that summarizes the results of studies with other methodological designs are useful in demonstrating their benefits in cardiovascular surgery services in Cuba and in other limited-resource settings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Estimate the effectiveness of improved recovery protocols in the perioperative evolution of patients undergoing cardiac surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We performed a systematic review and meta-analysis according to the guidelines of manual 5.1.0 for reviews of the Cochrane library. We included observational and quasi-experimental studies published from January 2015 through May 2020 that compared enhanced recovery protocols with conventional treatments in patients older than 18 years, and used a quality score to evaluate them. We used the following sources: the Cochrane Library, PubMed, LILACS, SciELO, EBSCO, Google Scholar, Web of Science, Clinical Key, ResearchGate and HINARI. The following keywords were used for the database searches in English: ERAS, protocols and cardiac surgery, enhanced recovery after cardiac surgery, ERACS, clinical pathway recovery and cardiac surgery, perioperative care and cardiac surgery. We used the following search terms for databases in Spanish: protocolos de recuperación precoz and cirugía cardiaca, protocolos de recuperación mejorada and cirugía cardiaca, cuidados perioperatorios and cirugía cardiaca, programas de recuperación precoz and cirugía cardiovascular. Methodological quality of included investigations was evaluated using the surgical research methodology scale. Meta-analyses were performed for perioperative complications, intensive care unit and hospital stays, and hospital readmission within 30 days of surgery. We calculated effect sizes of the interventions and the corresponding 95% confidence intervals. We used mean differences and confidence intervals for continuous variables, and for qualitative variables we calculated relative risk (RR). Random effects analysis was used. Heterogeneity of the studies was assessed using the Q statistic and the I2 statistic.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We selected 15 studies (a total of 5059 patients: study group, n = 1706; control group, ","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"23 3-4","pages":"46-53"},"PeriodicalIF":2.1,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9939117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Multiple Cause-of-Death Analysis to Estimate Systemic Autoimmune Disease Mortality Burden in Low- and Middle-Income Countries. 使用多死因分析来估计中低收入国家的系统性自身免疫性疾病死亡率负担
IF 2.1 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-04-01 Epub Date: 2021-04-30 DOI: 10.37757/MR2021.V23.N2.12
Halbert Hernández-Negrín, Yeniver Roque-Dapresa, Onan Martínez-Morales, Anabel Mederos-Portal

Autoimmune diseases are not always recognized as urgent health issues, despite a worldwide prevalence of 4%-5%. Most estimates come from high-income countries, as low- and middle-income countries face more issues of under-reporting. Despite this and the lack of recognition under current reporting practices, the role these diseases play in mortality must be acknowledged. In particular, considering multiple causes of death as opposed to a single cause of death results in a 1.5-4.2-fold increase in deaths classified as relating to autoimmune diseases, evidence of their share in overall mortality burden, a factor important for patient care and healthcare policy decision making. However, formulating such policies and programs for timely, appropriate diagnoses and care is stymied in low- and middle-income countries by the shortage of methodologically sound studies on mortality from systemic autoimmune diseases. This limitation exacerbates inequalities and health gaps among patients in different countries and localities. Multiple cause-of-death methodology has been validated for research on other diseases and demonstrates the mortality burden of these illnesses in countries where traditional methodological approaches, primarily based on prospective cohort studies, are not feasible. Studying mortality from systemic autoimmune diseases by analyzing multiple causes of death with data from national mortality registries is a low-cost alternative to traditional mortality analysis. The objective of this paper is to demonstrate and defend the usefulness of this approach to estimate mortality burden.

自身免疫性疾病并不总是被认为是紧急的健康问题,尽管全球患病率为4%-5%。大多数估计数来自高收入国家,因为低收入和中等收入国家面临更多的低报问题。尽管如此,而且在目前的报告做法下缺乏认识,但必须承认这些疾病在死亡率中所起的作用。特别是,考虑多种死亡原因而不是单一死亡原因会导致与自身免疫性疾病相关的死亡增加1.5-4.2倍,这是自身免疫性疾病在总死亡率负担中所占份额的证据,这是对患者护理和医疗保健政策决策的重要因素。然而,在低收入和中等收入国家,由于缺乏系统性自身免疫性疾病死亡率的方法学上可靠的研究,制定此类及时、适当诊断和护理的政策和规划受到阻碍。这一限制加剧了不同国家和地区患者之间的不平等和健康差距。多死因方法已在其他疾病的研究中得到验证,并表明在主要基于前瞻性队列研究的传统方法不可行的国家中,这些疾病的死亡率负担。利用国家死亡率登记数据分析多种死亡原因,研究系统性自身免疫性疾病的死亡率,是传统死亡率分析的一种低成本替代方法。本文的目的是证明和捍卫这种方法在估计死亡率负担方面的有用性。
{"title":"Using Multiple Cause-of-Death Analysis to Estimate Systemic Autoimmune Disease Mortality Burden in Low- and Middle-Income Countries.","authors":"Halbert Hernández-Negrín,&nbsp;Yeniver Roque-Dapresa,&nbsp;Onan Martínez-Morales,&nbsp;Anabel Mederos-Portal","doi":"10.37757/MR2021.V23.N2.12","DOIUrl":"https://doi.org/10.37757/MR2021.V23.N2.12","url":null,"abstract":"<p><p>Autoimmune diseases are not always recognized as urgent health issues, despite a worldwide prevalence of 4%-5%. Most estimates come from high-income countries, as low- and middle-income countries face more issues of under-reporting. Despite this and the lack of recognition under current reporting practices, the role these diseases play in mortality must be acknowledged. In particular, considering multiple causes of death as opposed to a single cause of death results in a 1.5-4.2-fold increase in deaths classified as relating to autoimmune diseases, evidence of their share in overall mortality burden, a factor important for patient care and healthcare policy decision making. However, formulating such policies and programs for timely, appropriate diagnoses and care is stymied in low- and middle-income countries by the shortage of methodologically sound studies on mortality from systemic autoimmune diseases. This limitation exacerbates inequalities and health gaps among patients in different countries and localities. Multiple cause-of-death methodology has been validated for research on other diseases and demonstrates the mortality burden of these illnesses in countries where traditional methodological approaches, primarily based on prospective cohort studies, are not feasible. Studying mortality from systemic autoimmune diseases by analyzing multiple causes of death with data from national mortality registries is a low-cost alternative to traditional mortality analysis. The objective of this paper is to demonstrate and defend the usefulness of this approach to estimate mortality burden.</p>","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"23 2","pages":"69"},"PeriodicalIF":2.1,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38900845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicc Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1